Cargando…
Health risks related to polyurethane foam degradation in CPAP devices used for sleep apnoea treatment
Patients with PUF-CPAP and especially those with pre-existing obstructive lung disease had increased use of anti-obstructive medication but there were no differences in hospitalisations and mortality, and data on cancer were inconclusive https://bit.ly/3uVIzXG
Autores principales: | Palm, Andreas, Grote, Ludger, Ekström, Magnus, Ljunggren, Mirjam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117731/ https://www.ncbi.nlm.nih.gov/pubmed/35144995 http://dx.doi.org/10.1183/13993003.00237-2022 |
Ejemplares similares
-
Cancer risk in adherent users of polyurethane foam-containing CPAP devices for sleep apnoea
por: Justeau, Grégoire, et al.
Publicado: (2022) -
Sleep apnoea management in Europe during the COVID-19 pandemic: data from the European Sleep Apnoea Database (ESADA)
por: Grote, Ludger, et al.
Publicado: (2020) -
High-sensitive cardiac troponin after CPAP in obstructive sleep apnoea: the adjusted analytical change limit (adjACL) for small variations at low concentrations
por: Monneret, Denis
Publicado: (2022) -
Socioeconomic Factors and Adherence to CPAP: The Population-Based Course of Disease in Patients Reported to the Swedish CPAP Oxygen and Ventilator Registry Study
por: Palm, Andreas, et al.
Publicado: (2021) -
Association between obstructive sleep apnoea and cancer: a cross-sectional, population-based study of the DISCOVERY cohort
por: Palm, Andreas, et al.
Publicado: (2023)